Alcon Inc (ALC)

Jun 3, 2025, 5:23 PM EDT - 5 days ago

LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

LNSR

May 28, 2025, 5:47 PM EDT - 11 days ago

US FDA approves Alcon's new dry-eye drug

May 28, 2025, 4:40 PM EDT - 11 days ago

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

May 26, 2025, 11:22 AM EDT - 13 days ago

Turkey Contact Lens Market - Competition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more

May 14, 2025, 12:03 PM EDT - 25 days ago

Alcon Inc. (ALC) Q1 2025 Earnings Call Transcript

May 14, 2025, 8:13 AM EDT - 25 days ago

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

GRAL

May 13, 2025, 4:30 PM EDT - 26 days ago

Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

May 6, 2025, 4:30 PM EDT - 4 weeks ago

Alcon Announces Results of 2025 Annual General Meeting

Apr 25, 2025, 8:00 AM EDT - 6 weeks ago

Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS

Apr 4, 2025, 1:00 AM EDT - 2 months ago

Alcon Publishes Agenda for 2025 Annual General Meeting

Apr 2, 2025, 8:00 AM EDT - 2 months ago

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

Mar 26, 2025, 4:30 PM EDT - 2 months ago

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

AURN

Mar 25, 2025, 1:00 AM EDT - 2 months ago

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

Mar 24, 2025, 8:00 AM EDT - 2 months ago

Alcon Agrees to Acquire LENSAR, Inc.

Mar 24, 2025, 5:15 AM EDT - 2 months ago

Retinal Surgery Devices Market Outlook Report 2025-2033: Revenues Set to Double, Reaching $4.83 Billion by 2033, Led by Topcon Corp., Alcon, and Carl Zeiss

Mar 13, 2025, 9:02 AM EDT - 3 months ago

Alcon to Host 2025 Capital Markets Day

Feb 27, 2025, 9:02 AM EST - 3 months ago

Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters

Feb 26, 2025, 8:54 PM EST - 3 months ago

Watch CNBC's full interview with Alcon CEO David Endicott

Feb 26, 2025, 11:51 AM EST - 3 months ago

Alcon Inc. (ALC) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 2:13 AM EST - 3 months ago

Alcon eyes revenue growth in 2025 after in-line results

Feb 25, 2025, 4:30 PM EST - 3 months ago

Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation

Feb 24, 2025, 8:02 AM EST - 3 months ago

Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet

Feb 19, 2025, 8:02 AM EST - 3 months ago

Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension

Dec 31, 2024, 4:30 PM EST - 5 months ago

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

Nov 14, 2024, 12:17 AM EST - 7 months ago

Alcon: Q3, Slight Guidance Cut Is Not Something Structural

Nov 13, 2024, 12:24 PM EST - 7 months ago

Alcon (ALC) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:17 AM EST - 7 months ago

Alcon cuts 2024 forecasts, as slow US hits surgical unit

Nov 12, 2024, 12:10 PM EST - 7 months ago

Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation

Oct 15, 2024, 2:04 PM EDT - 8 months ago

Aging population creates opportunity in these healthcare stocks, says Thornburg's Leveille

LLY NVO

Aug 22, 2024, 12:00 PM EDT - 10 months ago

Alcon Analysts Increase Their Forecasts After Q2 Results

Aug 22, 2024, 10:54 AM EDT - 10 months ago

Alcon CEO: 'Very good' revenue and underlying demand in Q2

Aug 21, 2024, 12:05 PM EDT - 10 months ago

Alcon Inc. (ALC) Q2 2024 Earnings Call Transcript

Aug 20, 2024, 4:30 PM EDT - 10 months ago

Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses

Jun 24, 2024, 1:00 AM EDT - 1 year ago

Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance

May 14, 2024, 10:48 AM EDT - 1 year ago

Alcon Inc. (ALC) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:30 PM EDT - 1 year ago

Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health

May 8, 2024, 4:30 PM EDT - 1 year ago

Alcon Announces Results of 2024 Annual General Meeting

Apr 7, 2024, 5:59 PM EDT - 1 year ago

Alcon Publishes Agenda for 2024 Annual General Meeting

Mar 6, 2024, 9:55 AM EST - 1 year ago

Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone

Feb 28, 2024, 9:45 PM EST - 1 year ago

Alcon, Inc. (ALC) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:30 PM EST - 1 year ago

Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023

Nov 15, 2023, 11:56 AM EST - 1 year ago

Alcon Inc. (ALC) Q3 2023 Earnings Call Transcript

Nov 15, 2023, 8:49 AM EST - 1 year ago

Alcon's stock falls as third-quarter sales miss estimates

Nov 14, 2023, 4:30 PM EST - 1 year ago

Alcon Reports Third Quarter 2023 Results

Oct 10, 2023, 1:03 PM EDT - 1 year ago

Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales

Aug 16, 2023, 11:29 AM EDT - 1 year ago

Alcon Inc. (ALC) Q2 2023 Earnings Call Transcript

Aug 15, 2023, 4:30 PM EDT - 1 year ago

Alcon Reports Second Quarter 2023 Results

Jul 26, 2023, 4:33 AM EDT - 2 years ago

Alcon: Lackluster Growth Given Its Valuation

Jun 27, 2023, 6:49 PM EDT - 2 years ago

Alcon: The Steady Force Of 'Boring'

May 11, 2023, 9:38 AM EDT - 2 years ago

Alcon CEO: Aging population and new technology driving eyecare business forward